Taiyen Biotech Co Ltd (1737) — Cash Flow-to-Debt Ratio
Taiyen Biotech Co Ltd (1737) has a Cash Flow-to-Debt Ratio of 0.06x as of June 2026, meaning its operating cash flow of NT$99.80 Million could theoretically repay 0% of its total liabilities (NT$1.67 Billion) in one year. See 1737 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Taiyen Biotech Co Ltd Cash Flow-to-Debt Ratio (2003–2025)
Historical debt coverage capacity for Taiyen Biotech Co Ltd across 23 annual periods. For the full cash flow conversion analysis, see 1737 cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Taiyen Biotech Co Ltd (2003–2025)
Year-by-year debt coverage analysis for Taiyen Biotech Co Ltd. Check cash flow quality index of Taiyen Biotech Co Ltd to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.33x | NT$473.77 Million | NT$1.45 Billion | ▼ -15.1% |
| 2024 | 0.39x | NT$660.12 Million | NT$1.71 Billion | ▲ +50.1% |
| 2023 | 0.26x | NT$454.54 Million | NT$1.77 Billion | ▼ -31.5% |
| 2022 | 0.37x | NT$580.69 Million | NT$1.55 Billion | ▲ +22.0% |
| 2021 | 0.31x | NT$600.08 Million | NT$1.95 Billion | ▲ +29.7% |
| 2020 | 0.24x | NT$339.36 Million | NT$1.43 Billion | ▲ +3.7% |
| 2019 | 0.23x | NT$330.81 Million | NT$1.45 Billion | ▼ -40.6% |
| 2018 | 0.38x | NT$449.83 Million | NT$1.17 Billion | ▼ -22.3% |
| 2017 | 0.49x | NT$607.87 Million | NT$1.23 Billion | ▼ -7.1% |
| 2016 | 0.53x | NT$568.06 Million | NT$1.07 Billion | ▲ +37.3% |
| 2015 | 0.39x | NT$383.93 Million | NT$990.08 Million | ▼ -4.6% |
| 2014 | 0.41x | NT$371.06 Million | NT$913.15 Million | ▼ -12.7% |
| 2013 | 0.47x | NT$203.21 Million | NT$436.66 Million | ▲ +3.2% |
| 2012 | 0.45x | NT$154.46 Million | NT$342.49 Million | ▼ -34.7% |
| 2011 | 0.69x | NT$246.09 Million | NT$356.53 Million | ▼ -15.3% |
| 2010 | 0.81x | NT$300.89 Million | NT$369.36 Million | ▼ -25.1% |
| 2009 | 1.09x | NT$358.02 Million | NT$329.10 Million | ▼ -20.2% |
| 2008 | 1.36x | NT$417.51 Million | NT$306.42 Million | ▲ +55.5% |
| 2007 | 0.88x | NT$322.49 Million | NT$367.92 Million | ▼ -5.9% |
| 2006 | 0.93x | NT$462.88 Million | NT$497.10 Million | ▲ +49.7% |
| 2005 | 0.62x | NT$575.91 Million | NT$925.79 Million | ▼ -56.3% |
| 2004 | 1.42x | NT$2.84 Billion | NT$1.99 Billion | ▲ +73.3% |
| 2003 | 0.82x | NT$3.42 Billion | NT$4.16 Billion | — |